Stay updated on Crenolanib with Salvage Chemo in R/R AML Clinical Trial

Sign up to get notified when there's something new on the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a pilot study combining crenolanib with standard salvage chemotherapy to treat patients with Relapsed/Refractory Acute Myeloid Leukemia (AML).
    Difference
    0.1%
    Check dated 2024-06-06T14:39:12.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying the inclusion criteria for patients with a confirmed diagnosis of AML. Previously, no information was provided under the Participation Criteria section.
    Difference
    48%
    Check dated 2024-05-22T21:24:39.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:49:22.000Z thumbnail image

Stay in the know with updates to Crenolanib with Salvage Chemo in R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page.